Zhichao Zhang

Dr. Zhichao Zhang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
ZZZhichao Zhang
Zhichao Zhang
ZZZijie Zhu
Zijie Zhu
BBBen Bazor
Ben Bazor
SLSueBin Lee
SueBin Lee
ZDZhi Ding
Zhi Ding
Tingrui PanTingrui Pan
Tingrui Pan
Objective: Human feet have long been considered in close association with whole-body health, from which abundant cardiovascular and skeletomuscular information can be extracted. In this study, we aim to develop the world's first foot-based wearable system that can detect both pedal pulses and muscular activities, referred to as FeetBeat. Methods: Utilizing the flexible iontronic sensing (FITS) technology, we have constructed and characterized a five-unit sensing array for detection of both pedal pulse signals and muscular activities. It is integrated into the tongue of an athletic shoe for real-time signal acquisition. Additionally, the linear array allows alignment-free capture of pulse signals and also provides a spatial reference to muscular activities. Results: An ultrahigh sensitivity of up to 1 nF/mmHg has been achieved for individual units, with a range of 1 to 200 mmHg. The pedal pulse waveforms have been detected to derive vital health signs, such as heart rates (HR) and respiratory rates, of which the pulse-derived HR is compared with the electrocardiogram (ECG). Moreover, individual tendon responses have been acquired to analyze different pedal gestures, from which multi-channel signals can be used to distinguish different activities. Conclusion: The FeetBeat device has shown the potential to be the world's first wearable platform to simultaneously analyze both vital signals and body activities from the measurable pedal pulse waveforms and muscular responses in a natural and unobtrusive fashion. The data-collecting wearable system provides a highly valuable means to assess the personalized health as well as daily activities on a continuous basis.

25 January 2021 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
ZZZhichao Zhang
Zhichao Zhang
RZRuoyu Zhang
Ruoyu Zhang
CCChi-Wei Chang
Chi-Wei Chang
YGYaojun Guo
Yaojun Guo
YCYung-Wei Chi
Yung-Wei Chi
Tingrui PanTingrui Pan
Tingrui Pan
Objective: Venous Thromboembolism (VTE) is a commonly underdiagnosed disease with severe consequences and an exceedingly high mortality rate. Conventional compression wraps are devised for therapeutic purpose but lack diagnostic capacity. Recent advances in flexible electronics and wearable technologies offer many possibilities for chronic disease management. In particular, vital signs have been studied to show a strong correlation with the risk of VTE patients. In this study, we aim to develop an intelligent theranostic compression device, referred to as iWRAP, with the built-in capacity of real-time vital sign monitoring together with auto-adjustable compression level. Methods: An instantaneous pneumatic feedback control with a high-resolution pressure sensor is integrated to provide a highly stabilized compression level at the prescribed interface pressure for an improved therapeutic outcome. Meanwhile, arterial pulse waveforms extracted from the pressure readings from the smart compression device can be utilized to derive the body vital signs, including heart rate (HR), respiratory rate (RR) and blood pressure (BP). Results: A reliable delivery of the targeted compression level within ±5% accuracy in the range of 20-60 mmHg has been achieved through the feedback of the interface pressure. Both HR and RR have been measured within clinical-grade accuracies. Moreover, BP estimated using an ALA model has been achieved at low compression levels, which is also within a clinical-acceptable accuracy. The acquired vital information has been instantaneously fit into the clinically acceptable criteria for life-threatening PE risk with timely assessments. Conclusion: The iWRAP has shown the potential to become the first theranostic wearable device with both continuous delivery of accurate and effective compression therapy and real-time monitoring of life-threatening conditions for VTE patients.

21 June 2023
Verified
Conference Paper
Open access
RZRuoyu Zhang
Ruoyu Zhang
RFRuijie Fang
Ruijie Fang
ZZZhichao Zhang
Zhichao Zhang
EHElahe Hosseini
Elahe Hosseini
MOMahdi Orooji
Mahdi Orooji
GGGozde Goncu-Berk
Gozde Goncu-Berk
The inability to sense the need to urinate is a persistent trouble for many individuals who have urinary incontinence. There are no products for people with urinary incontinence and their caregivers that target the elimination of involuntary urination instead of containing leaks or warning about leaks. Thus, fulfilling the real-time monitoring of the bladder to notify urination time holds a life-changing innovation potential for people with urinary incontinence. In this paper, we propose a low-cost wearable device in the form factor of an unobtrusive belt that uses bio-impedance measurement across the bladder region to notify the patients or caregivers about the need to urinate. We also present results from human subject tests using the proposed wearable prototype with a custom machine-learning algorithm to evaluate the accuracy of the system. Results from the human-subject tests showed an accuracy of over 90% on the binary task of full versus empty bladder states based on the change in bio-impedance values.